Fusarium, a significant emerging pathogen in patients with hematologic malignancy: Ten years' experience at a cancer center and implications for management
9242529
Boutati EI Anaissie EJ Fusarium, a significant emerging pathogen in patients with hematologic malignancy: Ten years' experience at a cancer center and implications for management Blood 1997 90 999-1008 9242529
Lack of activity of amphotericin B in systemic murine fusarial infection
1583339
Anaissie EJ Hachem R Legrand C Legenne P Nelson P Bodey GP Lack of activity of amphotericin B in systemic murine fusarial infection J Infect Dis 1992 165 1155-1157 1583339
The European Agency for the Evaluation of Medicinal Products Vfend (voriconazole) London Accessed October 4, 2005
The European Agency for the Evaluation of Medicinal Products Vfend (voriconazole), Scientific Discussion, European Public Assessment Report. London 2005 http://www.emea.eu.int/humandocs/Humans/EPAR/vfend/ vfend.htm Accessed October 4, 2005
Posaconazole as salvage treatment for invasive fusariosis in patients with underlying hematologic malignancy and other conditions
10.1086/503425 16619151
Raad II Hachem RY Herbrecht R Graybill JR Hare R Corcoran R Kontoyiannis DP Posaconazole as salvage treatment for invasive fusariosis in patients with underlying hematologic malignancy and other conditions Clin Infect Dis 2006 42 1398-403 10.1086/503425 16619151
Salvage therapy with voriconazole for invasive fungal infections in patients failing or intolerant to standard antifungal therapy
10.1097/01.TP.0000089109.42239.75 14702539
Baden LR Katz JT Fishman JA Koziol C Del Vecchio A Doran M Rubin RH Salvage therapy with voriconazole for invasive fungal infections in patients failing or intolerant to standard antifungal therapy Transplantation 2003 76 1632-1637 10.1097/01.TP.0000089109.42239.75 14702539
Rodriguez CA Lujan-Zilbermann J Woodard P Andreansky M Adderson EE Successful treatment of disseminated fusariosis Bone Marrow Transplant 2003 31 411-412 10.1038/sj.bmt.1703857 12634735
In vitro interactions of licensed and novel antifungal drugs against Fusarium spp
10.1016/j.diagmicrobio.2003.09.003 14761725
Ortoneda M Capilla J Javier Pastor F Pujol I Guarro J In vitro interactions of licensed and novel antifungal drugs against Fusarium spp Diagn Microbiol Infect Dis 2004 48 69-71 10.1016/ j.diagmicrobio.2003.09.003 14761725
Combinations of antifungal agents in therapy - What value are they?
10.1093/jac/dkh434 15375111
Cuenca-Estrella M Combinations of antifungal agents in therapy - what value are they? J Antimicrob Chemother 2004 54 854-869 10.1093/jac/ dkh434 15375111
In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp
127002 11751145 10.1128/AAC.46.1.245-247.2002
Arikan S Lozano-Chiu M Paetznick V Rex JH In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp Antimicrob Agents Chemother 2002 46 245-247 127002 11751145 10.1128/ AAC.46.1.245-247.2002
Caspofungin and amphotericin B for disseminated Fusarium verticillioides in leukemia
10.1345/aph.1D292 15956243
Makowsky MJ Warkentin DI Savoie ML Caspofungin and amphotericin B for disseminated Fusarium verticillioides in leukemia Ann Pharmacother 2005 39 1365-1366 10.1345/aph.1D292 15956243
Amphotericin B lipid complex and caspofungin as combination therapy for disseminated fusariosis in a patient with acute myeloid leukemia [abstract]
the International Society for Human and Animal Mycology
Fatoye A Bow EJ Loewen R Amphotericin B lipid complex and caspofungin as combination therapy for disseminated fusariosis in a patient with acute myeloid leukemia [abstract] Proceedings of the 13th Congress of the International Society for Human and Animal Mycology: 25-29 May 2003; San Antonio, TX the International Society for Human and Animal Mycology 2003 392
Resolution of fungemia due to Fusarium species in a patient with acute leukemia treated with caspofungin
10.1086/374895 12746788
Apostolidis J Bouzani M Platsouka E Belasiotou H Stamouli M Harhalakis N Boutati EI Paniara O Nikiforakis E Resolution of fungemia due to Fusarium species in a patient with acute leukemia treated with caspofungin Clin Infect Dis 2003 36 1349-1350 10.1086/374895 12746788